v3.26.1
Shareholders' Equity - Schedule of Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2023
Schedule of Stock Options [Abstract]      
Number of options, Outstanding, Balance (in Shares) 151,625 132,815  
Weighted average exercise price, Balance $ 9.48 $ 10.37  
Weighted average grant date fair value per share, Balance $ 5.56 $ 6.21  
Weighted average remaining contractual term (in years), Balance 7 years 5 months 4 days 8 years 7 months 2 days  
Aggregate intrinsic value, Balance (in Dollars) $ 437 $ 360  
Number of options, Vested and expected to vest (in Shares)   86,983  
Weighted average exercise price, Vested and expected to vest   $ 10.34  
Weighted average grant date fair value per share, Vested and expected to vest   $ 6.19  
Weighted average remaining contractual term (in years), Vested and expected to vest   8 years 5 months 12 days  
Aggregate intrinsic value, Vested and expected to vest (in Dollars)   $ 238  
Number of options, Exercisable (in Shares)   80,313  
Weighted average exercise price, Exercisable   $ 10.37  
Weighted average grant date fair value per share, Exercisable   $ 6.18  
Weighted average remaining contractual term (in years), Exercisable   8 years 5 months 1 day  
Aggregate intrinsic value, Exercisable (in Dollars)   $ 217  
Number of options, Granted (in Shares)   22,960  
Weighted average exercise price, Granted   $ 11.89  
Weighted average grant date fair value per share, Granted   $ 6.27
Number of options, Exercised (in Shares)   (41,770)  
Weighted average exercise price, Exercised   $ 7.98  
Weighted average grant date fair value per share, Exercised   $ 3.87